Assembly Biosciences Statistics Share Statistics Assembly Biosciences has 7.67M
shares outstanding. The number of shares has increased by 20.36%
in one year.
Shares Outstanding 7.67M Shares Change (YoY) 20.36% Shares Change (QoQ) 1.79% Owned by Institutions (%) 42.31% Shares Floating 3.59M Failed to Deliver (FTD) Shares 3 FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 530.93K, so 6.92% of the outstanding
shares have been sold short.
Short Interest 530.93K Short % of Shares Out 6.92% Short % of Float 9.91% Short Ratio (days to cover) 3.64
Valuation Ratios The PE ratio is -2.36 and the forward
PE ratio is -5.56.
Assembly Biosciences's PEG ratio is
0.05.
PE Ratio -2.36 Forward PE -5.56 PS Ratio 3.32 Forward PS 10.1 PB Ratio 2.84 P/FCF Ratio -1.85 PEG Ratio 0.05
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Assembly Biosciences.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 2.42,
with a Debt / Equity ratio of 0.09.
Current Ratio 2.42 Quick Ratio 2.42 Debt / Equity 0.09 Debt / EBITDA -0.07 Debt / FCF -0.06 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $390.68K Profits Per Employee $-550.37K Employee Count 73 Asset Turnover 0.24 Inventory Turnover n/a
Taxes Income Tax 330K Effective Tax Rate -0.83%
Stock Price Statistics The stock price has increased by 41.62% in the
last 52 weeks. The beta is 0.65, so Assembly Biosciences's
price volatility has been higher than the market average.
Beta 0.65 52-Week Price Change 41.62% 50-Day Moving Average 21.02 200-Day Moving Average 15.42 Relative Strength Index (RSI) 49.03 Average Volume (20 Days) 77,530
Income Statement In the last 12 months, Assembly Biosciences had revenue of 28.52M
and earned -40.18M
in profits. Earnings per share was -6.69.
Revenue 28.52M Gross Profit 28.39M Operating Income -45.42M Net Income -40.18M EBITDA -45.42M EBIT -45.42M Earnings Per Share (EPS) -6.69
Full Income Statement Balance Sheet The company has 38.34M in cash and 3.09M in
debt, giving a net cash position of 35.26M.
Cash & Cash Equivalents 38.34M Total Debt 3.09M Net Cash 35.26M Retained Earnings -825.92M Total Assets 80.78M Working Capital 30.18M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -51.12M
and capital expenditures -28K, giving a free cash flow of -51.15M.
Operating Cash Flow -51.12M Capital Expenditures -28K Free Cash Flow -51.15M FCF Per Share -8.52
Full Cash Flow Statement Margins Gross margin is 99.55%, with operating and profit margins of -159.26% and -140.87%.
Gross Margin 99.55% Operating Margin -159.26% Pretax Margin -139.72% Profit Margin -140.87% EBITDA Margin -159.26% EBIT Margin -159.26% FCF Margin -179.33%
Dividends & Yields ASMB does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for ASMB is $35,
which is 50.2% higher than the current price. The consensus rating is "Buy".
Price Target $35 Price Target Difference 50.2% Analyst Consensus Buy Analyst Count 3
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Feb 12, 2024. It was a
backward
split with a ratio of 1:12.
Last Split Date Feb 12, 2024 Split Type backward Split Ratio 1:12
Scores Altman Z-Score -13.87 Piotroski F-Score 1
